Chien-ShingChenMDPh.D.
Oncology • Loma Linda, CAHematologic Oncology
Professor of Medicine and Basic Sciences; Attending Physician, Medical Oncology & Hematology
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11175 Campus St
Chan Shun Pavilion # 11015
Loma Linda, CA 92354Phone+1 909-558-4910Fax+1 909-558-0219
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1998- University of Washington School of MedicineFellowship, Oncology/Bmt, 1995 - 1998
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1995
University of MinnesotaPh.D., Molecular Oncology/Pathobiology, 1988 - 1992
China Medical University (Taiwan) Class of 1985
Certifications & Licensure
CA State Medical License 1998 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) Start of enrollment: 2005 Mar 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Publications & Presentations
PubMed
- Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.Huynh Cao, Jeffrey Xiao, David J Baylink, Vinh Nguyen, Nathan Shim
Biomedicines. 2024-10-03 - Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia.Yi Xu, David J Baylink, Jeffrey Xiao, Lily Tran, Vinh Nguyen
International Journal of Molecular Sciences. 2024-08-05 - 1 citationsTransient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia.Yi Xu, David J Baylink, Chien-Shing Chen, Laren Tan, Jeffrey Xiao
Frontiers in Oncology. 2023-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
